PATENT CLAIM ANALYSIS

Application Number: 15953852
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "221000"]

Abstract:
The present invention relates to compounds, and pharmaceutically acceptable compositions thereof, useful as inhibitors of cyclophilins, and for the treatment of cyclophilin-related disorders.

Claim (Index 31):
The method of  claim 18 , wherein the compound selected from:

Metadata:
- Claim Count in Document: 44.0
- Percentile: 91.0
- Lexical Diversity: 1.17391
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15474193', '15701842', '15370645', '15620049', '14945610']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7340959119555912
- 35 USC 102 Novelty (BERT): 0.5239740749082819
- Combined Prediction Score: 0.7130837282508603
- Mean Citation Score: 230.281312
- Max Citation Score: 268.14297
- Similarity Product: 163.1476571832579

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test